CN Patent

CN102718750B — 含吖啶环的氨基吡啶类衍生物及其用途

Assigned to Institute of Pharmacology and Toxicology of AMMS · Expires 2015-03-11 · 11y expired

What this patent protects

本发明涉及含吖啶环的氨基吡啶类衍生物，具体涉及如式I或式II所示的化合物、其制备方法以及其用于制备抑制细胞过度增殖的药物的用途。本发明还涉及包含本发明化合物的药物组合物。本发明的化合物可用于治疗过度增殖性疾病，如癌症、神经性疼痛、炎症等。

USPTO Abstract

本发明涉及含吖啶环的氨基吡啶类衍生物，具体涉及如式I或式II所示的化合物、其制备方法以及其用于制备抑制细胞过度增殖的药物的用途。本发明还涉及包含本发明化合物的药物组合物。本发明的化合物可用于治疗过度增殖性疾病，如癌症、神经性疼痛、炎症等。

Drugs covered by this patent

cobimetinib-fumarate (COBIMETINIB FUMARATE)

Patent Metadata

Patent number: CN102718750B
Jurisdiction: CN
Classification: —
Expires: 2015-03-11
Drug substance claim: No
Drug product claim: No
Assignee: Institute of Pharmacology and Toxicology of AMMS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.